{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:04:09Z","timestamp":1769047449028,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"crossref","award":["4024"],"award-info":[{"award-number":["4024"]}],"id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jash.2016.12.004","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T17:46:35Z","timestamp":1482428795000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-4380","authenticated-orcid":false,"given":"Emi","family":"Ushigome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Oyabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Ushigome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2016.12.004_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2337\/diacare.12.8.573","article-title":"Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association","volume":"12","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2016.12.004_bib2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/HYPERTENSIONAHA.109.149336","article-title":"Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study","volume":"55","author":"Niiranen","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjhyper.2006.10.008","article-title":"Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement","volume":"20","author":"Matsui","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2016.12.004_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00380-010-0107-z","article-title":"Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes","volume":"26","author":"Ushigome","year":"2011","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jash.2016.12.004_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/HYPERTENSIONAHA.111.00138","article-title":"Home blood pressure variability as cardiovascular risk factor in the population of Ohasama","volume":"61","author":"Asayama","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.111.178657","article-title":"Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study","volume":"59","author":"Johansson","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/hr.2011.128","article-title":"The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus","volume":"34","author":"Ushigome","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2016.12.004_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/hr.2014.20","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)","volume":"37","author":"Shimamoto","year":"2014","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2016.12.004_bib9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2016.12.004_bib10","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1097\/HJH.0b013e3282ef7adc","article-title":"Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial)","volume":"25","author":"Ryuzaki","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2016.12.004_bib11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2016.12.004_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2008.102","article-title":"Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study","volume":"73","author":"Bakris","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2016.12.004_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/hr.2012.56","article-title":"The Japanese Society of Hypertension Guidelines for self-monitoring of blood pressure at home (Second Edition)","volume":"35","author":"Imai","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2016.12.004_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MBP.0b013e3283360e98","article-title":"European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults","volume":"15","author":"O\u2019Brien","year":"2010","journal-title":"Blood Press Monit"},{"issue":"Suppl 1","key":"10.1016\/j.jash.2016.12.004_bib15","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.diabres.2007.01.053","article-title":"Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy","volume":"77","author":"Yasuda","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jash.2016.12.004_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/HYPERTENSIONAHA.111.188706","article-title":"Cardiorenal syndrome: an evolutionary point of view","volume":"60","author":"Ito","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib17","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2016.12.004_bib18","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1001\/archinte.160.21.3301","article-title":"Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study","volume":"160","author":"Hozawa","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2016.12.004_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2016.12.004_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"Weber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2016.12.004_bib21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.111.189217","article-title":"Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretic","volume":"59","author":"Matsui","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/HYPERTENSIONAHA.112.193037","article-title":"Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring","volume":"59","author":"Parati","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.numecd.2005.06.010","article-title":"Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes","volume":"15","author":"Frontoni","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jash.2016.12.004_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00392-007-0535-7","article-title":"Treatment of hypertension in patients with diabetes mellitus","volume":"96","author":"Weck","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jash.2016.12.004_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.hco.0000240587.14463.58","article-title":"Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies","volume":"21","author":"Su","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jash.2016.12.004_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jash.2016.12.004_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/HYPERTENSIONAHA.111.174383","article-title":"Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study","volume":"58","author":"Zhang","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jdi.12052","article-title":"Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes","volume":"4","author":"Ushigome","year":"2013","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jash.2016.12.004_bib29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/jhh.2014.2","article-title":"Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study","volume":"28","author":"Ushigome","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2016.12.004_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/HYPERTENSIONAHA.110.157149","article-title":"Morning surge in blood pressure and cardiovascular risk: evidence and perspectives","volume":"56","author":"Kario","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2016.12.004_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/eurheartj\/ehq444","article-title":"Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients","volume":"32","author":"Kario","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2016.12.004_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.clinthera.2010.04.020","article-title":"Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study","volume":"32","author":"Shimada","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2016.12.004_bib33","first-page":"698","article-title":"Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity","volume":"57","author":"Nada","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"10.1016\/j.jash.2016.12.004_bib34","doi-asserted-by":"crossref","first-page":"e0125519","DOI":"10.1371\/journal.pone.0125519","article-title":"Comparison of Azelnidipine and Trichlormethiazide in Japanese type 2 diabetic patients with hypertension: The COAT Randomized Controlled Trial","volume":"10","author":"Takihata","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jash.2016.12.004_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/hr.2014.66","article-title":"Is home blood pressure reporting in patients with type 2 diabetes reliable?","volume":"37","author":"Matsumoto","year":"2014","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2016.12.004_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000330719","article-title":"Validation of the Omron M3 Intellisense (HEM-7051-E) upper arm blood pressure monitor, for self-measurement, according to the European Society of Hypertension International Protocol revision 2010 in a stage 3-5 chronic kidney disease population","volume":"35","author":"Akpolat","year":"2012","journal-title":"Kidney Blood Press Res"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116306039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171116306039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T13:46:43Z","timestamp":1549288003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171116306039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1933171116306039"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2016.12.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society of Hypertension. All rights reserved.","name":"copyright","label":"Copyright"}]}}